The FDA’s 23andMe decision will also change the rules for all at-home medical genetic testing
By Dave Gershgorn,
Quartz
| 04. 10. 2017
Doctors are losing their role as the gatekeeper of our health information, for better or worse.
Last week, the US Food and Drug Administration made a surprise announcement giving genetic testing company 23andMe clearance to sell a service that gives customers a risk analysis for 10 genetically linked diseases. It reverses a 2013 decision that cited concerns that inaccurate testing results—and potential customer misinterpretation—made for a public health threat, and builds on a 2015 agreement between the FDA and 23andMe that allowed the company to offer a test that told customers of their “carrier status” of genetic markers for certain diseases—but not assess their actual risk. This latest decision means 23andMe will again be able to provide specific risk analyses to customers, and perhaps more importantly, throws the door wide open to dozens of other companies to run out their own versions of at-home genetic risk-analysis products.
The disease risk that 23andMe offers isn’t a diagnosis; it just gives you your potential for elevated risk. For example, if a person inherited a copy of the ApoE4 gene variant from both...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
By Julie Métraux, Mother Jones | 09.23.2025